Table 2.
Parameter | Univariable analysis |
Multivariable analysis |
|||
---|---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | ||
Treatment (SOR+HAIC vs. SOR) | 0.88 (0.63–1.23) | 0.4521 | |||
Response (CR+PR vs. SD+PD) | 0.39 (0.26–0.58) | <0.0001 | 0.37 (0.24–0.57) | <0.0001 | |
Age (≥65 vs. <65) | 1.25 (0.87–1.78) | 0.2245 | |||
Sex (male vs. female) | 0.76 (0.47–1.22) | 0.2575 | |||
PS (1 vs. 0) | 2.17 (1.34–3.51) | 0.0015 | 1.88 (1.15–3.08) | 0.0122 | |
Vp (Vp1–4 vs. Vp0) | 0.88 (0.63–1.22) | 0.4384 | |||
Extrahepatic spread (yes vs. no) | 1.03 (0.70–1.51) | 0.8981 | |||
HBV (yes vs. no) | 1.15 (0.78–1.71) | 0.4753 | |||
HCV (yes vs. no) | 0.93 (0.66–1.30) | 0.6741 | |||
Albumin (≥3.6 vs. <3.6 mg/dL) | 0.80 (0.58–1.12) | 0.1976 | |||
Bilirubin (≥0.8 vs. <0.8 mg/dL) | 1.57 (1.12–2.21) | 0.0086 | 1.34 (0.95–1.89) | 0.0995 | |
ALBI grade (grade 2 vs. grade 1) | 1.26 (0.88–1.79) | 0.2019 | |||
AFP (≥400 vs. <400 ng/mL) | 1.68 (1.20–2.36) | 0.0024 | 1.84 (1.31–2.60) | 0.0005 | |
DCP (≥2,050 vs. <2,050 mAU/mL) | 1.05 (0.75–1.47) | 0.7610 |
All covariates were time-fixed except for response, which was time-dependent. OS, overall survival; ALBI grade, albumin-bilirubin grade; AFP, alfa-fetoprotein; DCP, des-γ-carboxy prothrombin.